Cedilla Therapeutics Appoints Delphine Collin, Ph.D., as Vice President, Biomolecular Sciences

29

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cedilla Therapeutics today announced the appointment of Delphine Collin, Ph.D., as vice president, biomolecular sciences. http://www.businesswire.com/news/home/20190514005180/en/Cedilla-Therapeutics-Appoints-Delphine-Collin-Ph.D.-Vice/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==